{"entity":{"type":"insider","cik":"0001291262","url":"/insider/0001291262","json_url":"/insider/0001291262.json","name":"Reed Douglas MD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":35,"n_filings":13,"first":"2006-03-03","last":"2018-10-24","span_basis":"filed_date"},"name_variants":[{"name":"Reed Douglas MD","source":"filing","n_filings":13,"first_seen":"2006-03-03","last_seen":"2018-10-24"}],"transactions":[{"id":6337861,"accession":"0001209191-18-056048","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-18-056048","line_url":"/filing/0001209191-18-056048","is_derivative":false,"issuer_cik":"0001169245","issuer_name":"PhaseBio Pharmaceuticals Inc","issuer_ticker":"PHAS","issuer_name_source":null,"issuer_url":"/issuer/0001169245","owner_cik":null,"owner_name":"Hatteras Venture Partners I, LP; Hatteras Ventures Partners III LP; LEE KENNETH B JR; Reed Douglas MD; Hatteras Venture Affiliates III Lp; INGRAM ROBERT ALEXANDER; Catalysta Ventures, LLC; Hatteras Venture Advisors III, LLC; Venture Capital Multiplier Fund; Crumpler John","owner_display_name":"Hatteras Venture Partners I, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":416481.0,"shares_owned_after_display":"416,481","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-22","filed_date":"2018-10-24","scope":"insider","n_lines":3},{"id":6016951,"accession":"0001209191-18-034839","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-034839","line_url":"/filing/0001209191-18-034839","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"LEE KENNETH B JR; Thorp Clay; Hatteras Venture Partners IV SBIC, LP; Crumpler John; Hatteras Venture Advisors IV SBIC, LLC; Reed Douglas MD; INGRAM ROBERT ALEXANDER","owner_display_name":"LEE KENNETH B JR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800000.0,"shares_display":"800,000","price_per_share":48.0,"price_display":"48.00","price_state":"stated","total_value":38400000.0,"total_display":"38,400,000.00","total_whole":"38,400,000","shares_owned_after":3279421.0,"shares_owned_after_display":"3,279,421","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-06-01","scope":"insider","n_lines":2},{"id":6454685,"accession":"0001209191-18-032789","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-18-032789","line_url":"/filing/0001209191-18-032789","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Reed Douglas MD; LEE KENNETH B JR; Thorp Clay; Crumpler John; INGRAM ROBERT ALEXANDER; Hatteras Venture Partners IV SBIC, LP; Hatteras Venture Advisors IV SBIC, LLC","owner_display_name":"Reed Douglas MD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":50.5,"price_display":"50.50","price_state":"stated","total_value":25250.0,"total_display":"25,250.00","total_whole":"25,250","shares_owned_after":4037737.0,"shares_owned_after_display":"4,037,737","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-23","filed_date":"2018-05-23","scope":"insider","n_lines":2},{"id":6454679,"accession":"0001209191-18-032789","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-032789","line_url":"/filing/0001209191-18-032789","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Reed Douglas MD; LEE KENNETH B JR; Thorp Clay; Crumpler John; INGRAM ROBERT ALEXANDER; Hatteras Venture Partners IV SBIC, LP; Hatteras Venture Advisors IV SBIC, LLC","owner_display_name":"Reed Douglas MD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5900.0,"shares_display":"5,900","price_per_share":50.85020616949153,"price_display":"50.85","price_state":"stated","total_value":300016.2164,"total_display":"300,016.22","total_whole":"300,016","shares_owned_after":4038519.0,"shares_owned_after_display":"4,038,519","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-22","filed_date":"2018-05-23","scope":"insider","n_lines":2},{"id":6454673,"accession":"0001209191-18-032789","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-032789","line_url":"/filing/0001209191-18-032789","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Reed Douglas MD; LEE KENNETH B JR; Thorp Clay; Crumpler John; INGRAM ROBERT ALEXANDER; Hatteras Venture Partners IV SBIC, LP; Hatteras Venture Advisors IV SBIC, LLC","owner_display_name":"Reed Douglas MD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31100.0,"shares_display":"31,100","price_per_share":51.17078287781351,"price_display":"51.17","price_state":"stated","total_value":1591411.3475,"total_display":"1,591,411.35","total_whole":"1,591,411","shares_owned_after":4046206.0,"shares_owned_after_display":"4,046,206","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-21","filed_date":"2018-05-23","scope":"insider","n_lines":4},{"id":4783134,"accession":"0001209191-17-035173","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-035173","line_url":"/filing/0001209191-17-035173#line-4","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Hatteras Venture Advisors IV SBIC, LLC; LEE KENNETH B JR; Reed Douglas MD; Hatteras Venture Partners IV SBIC, LP; Crumpler John; INGRAM ROBERT ALEXANDER; Thorp Clay","owner_display_name":"Hatteras Venture Advisors IV SBIC, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":133333.0,"shares_display":"133,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1999995.0,"total_display":"1,999,995.00","total_whole":"1,999,995","shares_owned_after":3861797.0,"shares_owned_after_display":"3,861,797","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-22","filed_date":"2017-05-24","scope":"insider"},{"id":4712836,"accession":"0001578563-17-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001578563-17-000002","line_url":"/filing/0001578563-17-000002#line-3","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Hatteras Ventures Partners III LP; Hatteras Venture Advisors III, LLC; LEE KENNETH B JR; Thorp Clay; Crumpler John; Reed Douglas MD; Hatteras Venture Affiliates III Lp; INGRAM ROBERT ALEXANDER","owner_display_name":"Hatteras Ventures Partners III LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6478.0,"shares_display":"6,478","price_per_share":8.22,"price_display":"8.22","price_state":"stated","total_value":53249.16,"total_display":"53,249.16","total_whole":"53,249","shares_owned_after":1757719.0,"shares_owned_after_display":"1,757,719","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-01-19","filed_date":"2017-01-19","scope":"insider"},{"id":4263590,"accession":"0001578563-17-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001578563-17-000004","line_url":"/filing/0001578563-17-000004#line-3","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Hatteras Venture Partners IV SBIC, LP; Hatteras Venture Advisors IV SBIC, LLC; Thorp Clay; Reed Douglas MD; INGRAM ROBERT ALEXANDER; Crumpler John; LEE KENNETH B JR","owner_display_name":"Hatteras Venture Partners IV SBIC, LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7592.0,"shares_display":"7,592","price_per_share":8.22,"price_display":"8.22","price_state":"stated","total_value":62406.24,"total_display":"62,406.24","total_whole":"62,406","shares_owned_after":2060514.0,"shares_owned_after_display":"2,060,514","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-01-19","filed_date":"2017-01-19","scope":"insider"},{"id":4712832,"accession":"0001578563-17-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001578563-17-000002","line_url":"/filing/0001578563-17-000002#line-2","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Hatteras Ventures Partners III LP; Hatteras Venture Advisors III, LLC; LEE KENNETH B JR; Thorp Clay; Crumpler John; Reed Douglas MD; Hatteras Venture Affiliates III Lp; INGRAM ROBERT ALEXANDER","owner_display_name":"Hatteras Ventures Partners III LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10457.0,"shares_display":"10,457","price_per_share":8.64,"price_display":"8.64","price_state":"stated","total_value":90348.48,"total_display":"90,348.48","total_whole":"90,348","shares_owned_after":1764197.0,"shares_owned_after_display":"1,764,197","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-01-18","filed_date":"2017-01-19","scope":"insider"},{"id":4263587,"accession":"0001578563-17-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001578563-17-000004","line_url":"/filing/0001578563-17-000004#line-2","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Hatteras Venture Partners IV SBIC, LP; Hatteras Venture Advisors IV SBIC, LLC; Thorp Clay; Reed Douglas MD; INGRAM ROBERT ALEXANDER; Crumpler John; LEE KENNETH B JR","owner_display_name":"Hatteras Venture Partners IV SBIC, LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12258.0,"shares_display":"12,258","price_per_share":8.64,"price_display":"8.64","price_state":"stated","total_value":105909.12,"total_display":"105,909.12","total_whole":"105,909","shares_owned_after":2068106.0,"shares_owned_after_display":"2,068,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-01-18","filed_date":"2017-01-19","scope":"insider"},{"id":4712827,"accession":"0001578563-17-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-17-000002","line_url":"/filing/0001578563-17-000002#line-1","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Hatteras Ventures Partners III LP; Hatteras Venture Advisors III, LLC; LEE KENNETH B JR; Thorp Clay; Crumpler John; Reed Douglas MD; Hatteras Venture Affiliates III Lp; INGRAM ROBERT ALEXANDER","owner_display_name":"Hatteras Ventures Partners III LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8366.0,"shares_display":"8,366","price_per_share":8.92,"price_display":"8.92","price_state":"stated","total_value":74624.72,"total_display":"74,624.72","total_whole":"74,625","shares_owned_after":1774654.0,"shares_owned_after_display":"1,774,654","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-01-17","filed_date":"2017-01-19","scope":"insider"},{"id":4263584,"accession":"0001578563-17-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-17-000004","line_url":"/filing/0001578563-17-000004#line-1","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Hatteras Venture Partners IV SBIC, LP; Hatteras Venture Advisors IV SBIC, LLC; Thorp Clay; Reed Douglas MD; INGRAM ROBERT ALEXANDER; Crumpler John; LEE KENNETH B JR","owner_display_name":"Hatteras Venture Partners IV SBIC, LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9806.0,"shares_display":"9,806","price_per_share":8.92,"price_display":"8.92","price_state":"stated","total_value":87469.52,"total_display":"87,469.52","total_whole":"87,470","shares_owned_after":2080364.0,"shares_owned_after_display":"2,080,364","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-01-17","filed_date":"2017-01-19","scope":"insider"},{"id":2959330,"accession":"0001209191-16-126262","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-126262","line_url":"/filing/0001209191-16-126262#line-3","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Hatteras Venture Advisors IV SBIC, LLC; Reed Douglas MD; LEE KENNETH B JR; Hatteras Venture Partners IV SBIC, LP; Crumpler John; Thorp Clay; INGRAM ROBERT ALEXANDER","owner_display_name":"Hatteras Venture Advisors IV SBIC, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69.0,"shares_display":"69","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":483.0,"total_display":"483.00","total_whole":"483","shares_owned_after":1675884.0,"shares_owned_after_display":"1,675,884","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-07","scope":"insider"},{"id":2959324,"accession":"0001209191-16-126262","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-126262","line_url":"/filing/0001209191-16-126262#line-2","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Hatteras Venture Advisors IV SBIC, LLC; Reed Douglas MD; LEE KENNETH B JR; Hatteras Venture Partners IV SBIC, LP; Crumpler John; Thorp Clay; INGRAM ROBERT ALEXANDER","owner_display_name":"Hatteras Venture Advisors IV SBIC, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":414286.0,"shares_display":"414,286","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2900002.0,"total_display":"2,900,002.00","total_whole":"2,900,002","shares_owned_after":2090170.0,"shares_owned_after_display":"2,090,170","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-07","scope":"insider"},{"id":2179228,"accession":"0001209191-16-126263","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-126263","line_url":"/filing/0001209191-16-126263#line-3","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Hatteras Ventures Partners III LP; Reed Douglas MD; Hatteras Venture Affiliates III Lp; INGRAM ROBERT ALEXANDER; Hatteras Venture Advisors III, LLC; LEE KENNETH B JR; Crumpler John; Thorp Clay","owner_display_name":"Hatteras Ventures Partners III LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69.0,"shares_display":"69","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":483.0,"total_display":"483.00","total_whole":"483","shares_owned_after":1675878.0,"shares_owned_after_display":"1,675,878","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-07","scope":"insider"},{"id":2179226,"accession":"0001209191-16-126263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-126263","line_url":"/filing/0001209191-16-126263#line-2","is_derivative":false,"issuer_cik":"0001208570","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001208570","owner_cik":null,"owner_name":"Hatteras Ventures Partners III LP; Reed Douglas MD; Hatteras Venture Affiliates III Lp; INGRAM ROBERT ALEXANDER; Hatteras Venture Advisors III, LLC; LEE KENNETH B JR; Crumpler John; Thorp Clay","owner_display_name":"Hatteras Ventures Partners III LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":107142.0,"shares_display":"107,142","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":749994.0,"total_display":"749,994.00","total_whole":"749,994","shares_owned_after":1783020.0,"shares_owned_after_display":"1,783,020","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-07","scope":"insider"},{"id":4342609,"accession":"0001192482-13-000238","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001192482-13-000238","line_url":"/filing/0001192482-13-000238#line-3","is_derivative":false,"issuer_cik":"0001291262","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001291262","owner_cik":"0001291262","owner_name":"Reed Douglas MD","owner_display_name":"Reed Douglas MD","owner_url":"/insider/0001291262","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":142857.0,"shares_display":"142,857","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":999999.0,"total_display":"999,999.00","total_whole":"999,999","shares_owned_after":142857.0,"shares_owned_after_display":"142,857","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-12-17","filed_date":"2013-12-19","scope":"insider"},{"id":7390310,"accession":"0001005477-07-004709","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005477-07-004709","line_url":"/filing/0001005477-07-004709#line-1","is_derivative":false,"issuer_cik":"0000707388","issuer_name":"DIGIRAD CORP","issuer_ticker":"DRAD","issuer_name_source":null,"issuer_url":"/issuer/0000707388","owner_cik":"0001291262","owner_name":"Reed Douglas MD","owner_display_name":"Reed Douglas MD","owner_url":"/insider/0001291262","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":3.05,"price_display":"3.05","price_state":"stated","total_value":91500.0,"total_display":"91,500.00","total_whole":"91,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-24","filed_date":"2007-08-27","scope":"insider"},{"id":8107824,"accession":"0001005477-07-003310","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001005477-07-003310","line_url":"/filing/0001005477-07-003310#line-3","is_derivative":false,"issuer_cik":"0000707388","issuer_name":"DIGIRAD CORP","issuer_ticker":"DRAD","issuer_name_source":null,"issuer_url":"/issuer/0000707388","owner_cik":"0001291262","owner_name":"Reed Douglas MD","owner_display_name":"Reed Douglas MD","owner_url":"/insider/0001291262","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54500.0,"shares_display":"54,500","price_per_share":4.309,"price_display":"4.31","price_state":"stated","total_value":234840.5,"total_display":"234,840.50","total_whole":"234,841","shares_owned_after":831312.0,"shares_owned_after_display":"831,312","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-29","filed_date":"2007-05-29","scope":"insider"},{"id":8107821,"accession":"0001005477-07-003310","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005477-07-003310","line_url":"/filing/0001005477-07-003310#line-2","is_derivative":false,"issuer_cik":"0000707388","issuer_name":"DIGIRAD CORP","issuer_ticker":"DRAD","issuer_name_source":null,"issuer_url":"/issuer/0000707388","owner_cik":"0001291262","owner_name":"Reed Douglas MD","owner_display_name":"Reed Douglas MD","owner_url":"/insider/0001291262","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13400.0,"shares_display":"13,400","price_per_share":4.3432,"price_display":"4.34","price_state":"stated","total_value":58198.88,"total_display":"58,198.88","total_whole":"58,199","shares_owned_after":885812.0,"shares_owned_after_display":"885,812","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-25","filed_date":"2007-05-29","scope":"insider"},{"id":8107815,"accession":"0001005477-07-003310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005477-07-003310","line_url":"/filing/0001005477-07-003310#line-1","is_derivative":false,"issuer_cik":"0000707388","issuer_name":"DIGIRAD CORP","issuer_ticker":"DRAD","issuer_name_source":null,"issuer_url":"/issuer/0000707388","owner_cik":"0001291262","owner_name":"Reed Douglas MD","owner_display_name":"Reed Douglas MD","owner_url":"/insider/0001291262","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":4.4,"price_display":"4.40","price_state":"stated","total_value":9240.0,"total_display":"9,240.00","total_whole":"9,240","shares_owned_after":899212.0,"shares_owned_after_display":"899,212","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-24","filed_date":"2007-05-29","scope":"insider"},{"id":9214410,"accession":"0001005477-06-001663","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001005477-06-001663","line_url":"/filing/0001005477-06-001663#line-3","is_derivative":false,"issuer_cik":"0001291262","issuer_name":"DIGIRAD CORP","issuer_ticker":"DRAD","issuer_name_source":null,"issuer_url":"/issuer/0001291262","owner_cik":"0001291262","owner_name":"Reed Douglas MD","owner_display_name":"Reed Douglas MD","owner_url":"/insider/0001291262","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":19200.0,"total_display":"19,200.00","total_whole":"19,200","shares_owned_after":901312.0,"shares_owned_after_display":"901,312","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-02-28","filed_date":"2006-03-07","scope":"insider"},{"id":9214405,"accession":"0001005477-06-001582","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001005477-06-001582","line_url":"/filing/0001005477-06-001582#line-3","is_derivative":false,"issuer_cik":"0001291262","issuer_name":"DIGIRAD CORP","issuer_ticker":"DRAD","issuer_name_source":null,"issuer_url":"/issuer/0001291262","owner_cik":"0001291262","owner_name":"Reed Douglas MD","owner_display_name":"Reed Douglas MD","owner_url":"/insider/0001291262","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":19200.0,"total_display":"19,200.00","total_whole":"19,200","shares_owned_after":2107841.0,"shares_owned_after_display":"2,107,841","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-02-28","filed_date":"2006-03-03","scope":"insider"},{"id":9214409,"accession":"0001005477-06-001663","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005477-06-001663","line_url":"/filing/0001005477-06-001663#line-2","is_derivative":false,"issuer_cik":"0001291262","issuer_name":"DIGIRAD CORP","issuer_ticker":"DRAD","issuer_name_source":null,"issuer_url":"/issuer/0001291262","owner_cik":"0001291262","owner_name":"Reed Douglas MD","owner_display_name":"Reed Douglas MD","owner_url":"/insider/0001291262","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13200.0,"shares_display":"13,200","price_per_share":3.97,"price_display":"3.97","price_state":"stated","total_value":52404.0,"total_display":"52,404.00","total_whole":"52,404","shares_owned_after":906112.0,"shares_owned_after_display":"906,112","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-02-27","filed_date":"2006-03-07","scope":"insider"},{"id":9214403,"accession":"0001005477-06-001582","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005477-06-001582","line_url":"/filing/0001005477-06-001582#line-2","is_derivative":false,"issuer_cik":"0001291262","issuer_name":"DIGIRAD CORP","issuer_ticker":"DRAD","issuer_name_source":null,"issuer_url":"/issuer/0001291262","owner_cik":"0001291262","owner_name":"Reed Douglas MD","owner_display_name":"Reed Douglas MD","owner_url":"/insider/0001291262","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13200.0,"shares_display":"13,200","price_per_share":3.97,"price_display":"3.97","price_state":"stated","total_value":52404.0,"total_display":"52,404.00","total_whole":"52,404","shares_owned_after":2112641.0,"shares_owned_after_display":"2,112,641","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-02-27","filed_date":"2006-03-03","scope":"insider"},{"id":9214408,"accession":"0001005477-06-001663","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005477-06-001663","line_url":"/filing/0001005477-06-001663#line-1","is_derivative":false,"issuer_cik":"0001291262","issuer_name":"DIGIRAD CORP","issuer_ticker":"DRAD","issuer_name_source":null,"issuer_url":"/issuer/0001291262","owner_cik":"0001291262","owner_name":"Reed Douglas MD","owner_display_name":"Reed Douglas MD","owner_url":"/insider/0001291262","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":3.9502,"price_display":"3.95","price_state":"stated","total_value":39502.0,"total_display":"39,502.00","total_whole":"39,502","shares_owned_after":919312.0,"shares_owned_after_display":"919,312","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-02-24","filed_date":"2006-03-07","scope":"insider"},{"id":9214404,"accession":"0001005477-06-001582","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005477-06-001582","line_url":"/filing/0001005477-06-001582#line-1","is_derivative":false,"issuer_cik":"0001291262","issuer_name":"DIGIRAD CORP","issuer_ticker":"DRAD","issuer_name_source":null,"issuer_url":"/issuer/0001291262","owner_cik":"0001291262","owner_name":"Reed Douglas MD","owner_display_name":"Reed Douglas MD","owner_url":"/insider/0001291262","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":3.9502,"price_display":"3.95","price_state":"stated","total_value":39502.0,"total_display":"39,502.00","total_whole":"39,502","shares_owned_after":2125841.0,"shares_owned_after_display":"2,125,841","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-02-24","filed_date":"2006-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001169245","name":"PhaseBio Pharmaceuticals Inc","url":"/issuer/0001169245","role":"Ten percent owner","n_filings":1,"first_seen":"2018-10-24","last_seen":"2018-10-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001560241","name":"G1 Therapeutics, Inc.","url":"/issuer/0001560241","role":"Ten percent owner","n_filings":3,"first_seen":"2017-05-24","last_seen":"2018-06-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001539029","name":"Clearside Biomedical, Inc.","url":"/issuer/0001539029","role":"Ten percent owner, Other","n_filings":4,"first_seen":"2016-06-07","last_seen":"2017-01-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001361248","name":"TETRALOGIC PHARMACEUTICALS CORP","url":"/issuer/0001361248","role":"Director","n_filings":1,"first_seen":"2013-12-19","last_seen":"2013-12-19"},{"type":"issuer","type_label":"ISSUER","cik":"0000707388","name":"DIGIRAD CORP","url":"/issuer/0000707388","role":"Director","n_filings":4,"first_seen":"2006-03-03","last_seen":"2007-08-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001291262","retrieved_at":"2026-08-23T22:34:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}